Article
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
Inflammatory bowel diseases - 1 Oct 2015
Stallhofer Johannes, Friedrich Matthias, Konrad-Zerna Astrid, Wetzke Martin, Lohse Peter, Glas Jürgen, Tillack-Schreiber Cornelia, Schnitzler Fabian, Beigel Florian, Brand Stephan
Abstract excerpt
BACKGROUND: Lipocalin-2 (LCN2) is a potent bacteriostatic protein. We aimed to investigate its role as a disease activity marker in patients with inflammatory bowel disease (IBD) and its induction by the Th17 cytokines IL-17A, IL-22, and TNF-α in colonic epithelial cells. Moreover, we analyzed the influence of IBD-associated IL23R alleles on LCN2 serum levels in IBD patients. METHODS: LCN2 serum levels were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
